

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 6.08239561 |
| 2 | neutrophil activation involved in immune response (GO:0002283) | 5.13288933 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.94958611 |
| 4 | negative regulation of cell killing (GO:0031342) | 4.85229126 |
| 5 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.85229126 |
| 6 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.75935117 |
| 7 | response to peptidoglycan (GO:0032494) | 4.74981287 |
| 8 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.55372826 |
| 9 | DNA strand elongation (GO:0022616) | 4.30885535 |
| 10 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.30868552 |
| 11 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.30868552 |
| 12 | modulation by symbiont of host immune response (GO:0052553) | 4.30868552 |
| 13 | positive regulation by symbiont of host defense response (GO:0052509) | 4.30868552 |
| 14 | modulation by symbiont of host defense response (GO:0052031) | 4.30868552 |
| 15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.30868552 |
| 16 | detection of other organism (GO:0098543) | 4.25195663 |
| 17 | detection of bacterium (GO:0016045) | 4.24751827 |
| 18 | ribosomal small subunit assembly (GO:0000028) | 4.23270734 |
| 19 | immunoglobulin mediated immune response (GO:0016064) | 4.22802702 |
| 20 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.19862276 |
| 21 | viral transcription (GO:0019083) | 4.15026306 |
| 22 | glycine metabolic process (GO:0006544) | 4.12408733 |
| 23 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.05376286 |
| 24 | regulation of mast cell degranulation (GO:0043304) | 4.00065853 |
| 25 | translational termination (GO:0006415) | 3.99832050 |
| 26 | macrophage activation involved in immune response (GO:0002281) | 3.98131390 |
| 27 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.91965718 |
| 28 | germinal center formation (GO:0002467) | 3.88829662 |
| 29 | cellular extravasation (GO:0045123) | 3.87212177 |
| 30 | telomere maintenance via recombination (GO:0000722) | 3.86627542 |
| 31 | maturation of SSU-rRNA (GO:0030490) | 3.86556465 |
| 32 | DNA unwinding involved in DNA replication (GO:0006268) | 3.85205433 |
| 33 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.83756026 |
| 34 | DNA replication initiation (GO:0006270) | 3.82060655 |
| 35 | positive regulation of antigen processing and presentation (GO:0002579) | 3.81306260 |
| 36 | positive regulation of B cell differentiation (GO:0045579) | 3.80542005 |
| 37 | translational elongation (GO:0006414) | 3.71619586 |
| 38 | B cell receptor signaling pathway (GO:0050853) | 3.69890765 |
| 39 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.67192052 |
| 40 | nucleobase biosynthetic process (GO:0046112) | 3.62065363 |
| 41 | regulation of antigen processing and presentation (GO:0002577) | 3.58235366 |
| 42 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.55771186 |
| 43 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.55098923 |
| 44 | mitotic recombination (GO:0006312) | 3.53801141 |
| 45 | negative regulation of interleukin-12 production (GO:0032695) | 3.53738603 |
| 46 | L-serine metabolic process (GO:0006563) | 3.51750108 |
| 47 | regulation of leukocyte degranulation (GO:0043300) | 3.50926317 |
| 48 | detection of external biotic stimulus (GO:0098581) | 3.50471561 |
| 49 | serine family amino acid biosynthetic process (GO:0009070) | 3.49053277 |
| 50 | neutrophil activation (GO:0042119) | 3.48659797 |
| 51 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.47123783 |
| 52 | telomere maintenance via telomere lengthening (GO:0010833) | 3.44584958 |
| 53 | myeloid cell activation involved in immune response (GO:0002275) | 3.44119320 |
| 54 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.43607845 |
| 55 | respiratory burst (GO:0045730) | 3.42206181 |
| 56 | neutrophil mediated immunity (GO:0002446) | 3.40441938 |
| 57 | NIK/NF-kappaB signaling (GO:0038061) | 3.39777301 |
| 58 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.38471344 |
| 59 | L-phenylalanine metabolic process (GO:0006558) | 3.38471344 |
| 60 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.36897661 |
| 61 | positive thymic T cell selection (GO:0045059) | 3.35877550 |
| 62 | positive regulation of mast cell activation (GO:0033005) | 3.34280994 |
| 63 | purine nucleobase biosynthetic process (GO:0009113) | 3.33286569 |
| 64 | translational initiation (GO:0006413) | 3.32220931 |
| 65 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.32130701 |
| 66 | positive regulation of mast cell degranulation (GO:0043306) | 3.32130701 |
| 67 | L-phenylalanine catabolic process (GO:0006559) | 3.31375649 |
| 68 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.31375649 |
| 69 | regulation of B cell differentiation (GO:0045577) | 3.29721641 |
| 70 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.29229207 |
| 71 | cotranslational protein targeting to membrane (GO:0006613) | 3.26435772 |
| 72 | granulocyte activation (GO:0036230) | 3.26152047 |
| 73 | protein targeting to ER (GO:0045047) | 3.24767298 |
| 74 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.23442390 |
| 75 | response to muramyl dipeptide (GO:0032495) | 3.20984624 |
| 76 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.20677627 |
| 77 | ribosomal small subunit biogenesis (GO:0042274) | 3.20171649 |
| 78 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.20073002 |
| 79 | aromatic amino acid family catabolic process (GO:0009074) | 3.19716296 |
| 80 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.18917167 |
| 81 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.17108905 |
| 82 | response to host immune response (GO:0052572) | 3.17108905 |
| 83 | mannose metabolic process (GO:0006013) | 3.15808792 |
| 84 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.14716488 |
| 85 | ribosomal large subunit biogenesis (GO:0042273) | 3.14149481 |
| 86 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.13352621 |
| 87 | serine family amino acid catabolic process (GO:0009071) | 3.11288794 |
| 88 | tryptophan catabolic process (GO:0006569) | 3.11106187 |
| 89 | indole-containing compound catabolic process (GO:0042436) | 3.11106187 |
| 90 | indolalkylamine catabolic process (GO:0046218) | 3.11106187 |
| 91 | cellular protein complex disassembly (GO:0043624) | 3.10836362 |
| 92 | detection of biotic stimulus (GO:0009595) | 3.10530400 |
| 93 | folic acid metabolic process (GO:0046655) | 3.10259932 |
| 94 | regulation of mast cell activation (GO:0033003) | 3.09473287 |
| 95 | protein localization to endoplasmic reticulum (GO:0070972) | 3.06124382 |
| 96 | B cell mediated immunity (GO:0019724) | 3.05115467 |
| 97 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.04558417 |
| 98 | negative thymic T cell selection (GO:0045060) | 3.04528826 |
| 99 | leukocyte aggregation (GO:0070486) | 3.03881241 |
| 100 | protein localization to kinetochore (GO:0034501) | 3.02665942 |
| 101 | serine family amino acid metabolic process (GO:0009069) | 3.02396730 |
| 102 | macrophage activation (GO:0042116) | 3.00860954 |
| 103 | rRNA processing (GO:0006364) | 3.00740160 |
| 104 | viral life cycle (GO:0019058) | 3.00273713 |
| 105 | kynurenine metabolic process (GO:0070189) | 2.99822778 |
| 106 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.99368107 |
| 107 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.98110497 |
| 108 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.97905601 |
| 109 | DNA replication checkpoint (GO:0000076) | 2.95933949 |
| 110 | ribosome biogenesis (GO:0042254) | 2.95129637 |
| 111 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.94783574 |
| 112 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.93711890 |
| 113 | pseudouridine synthesis (GO:0001522) | 2.93536492 |
| 114 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.92829036 |
| 115 | detection of molecule of bacterial origin (GO:0032490) | 2.92751986 |
| 116 | N-acetylneuraminate metabolic process (GO:0006054) | 2.91295781 |
| 117 | mitochondrial DNA replication (GO:0006264) | 2.91229724 |
| 118 | rRNA metabolic process (GO:0016072) | 2.90752667 |
| 119 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.90410432 |
| 120 | T cell selection (GO:0045058) | 2.89452124 |
| 121 | nucleoside salvage (GO:0043174) | 2.89418185 |
| 122 | response to host defenses (GO:0052200) | 2.88593296 |
| 123 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.88593296 |
| 124 | response to host (GO:0075136) | 2.88593296 |
| 125 | tryptophan metabolic process (GO:0006568) | 2.87775462 |
| 126 | imidazole-containing compound metabolic process (GO:0052803) | 2.85820627 |
| 127 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.85713612 |
| 128 | one-carbon metabolic process (GO:0006730) | 2.85580889 |
| 129 | tetrahydrofolate metabolic process (GO:0046653) | 2.85551177 |
| 130 | positive regulation of chemokine secretion (GO:0090197) | 2.85344123 |
| 131 | thymic T cell selection (GO:0045061) | 2.84878445 |
| 132 | protein complex disassembly (GO:0043241) | 2.84810400 |
| 133 | regulation of gamma-delta T cell activation (GO:0046643) | 2.84775815 |
| 134 | defense response to protozoan (GO:0042832) | 2.82152129 |
| 135 | mitochondrial DNA metabolic process (GO:0032042) | 2.81911910 |
| 136 | glyoxylate metabolic process (GO:0046487) | 2.81021719 |
| 137 | microglial cell activation (GO:0001774) | 2.80559115 |
| 138 | positive regulation of granulocyte differentiation (GO:0030854) | 2.79860661 |
| 139 | amino sugar catabolic process (GO:0046348) | 2.79465399 |
| 140 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.79250720 |
| 141 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.78644252 |
| 142 | chromatin remodeling at centromere (GO:0031055) | 2.78253175 |
| 143 | response to protozoan (GO:0001562) | 2.78162908 |
| 144 | CENP-A containing nucleosome assembly (GO:0034080) | 2.77199117 |
| 145 | regulation of regulated secretory pathway (GO:1903305) | 2.76137372 |
| 146 | myeloid leukocyte mediated immunity (GO:0002444) | 2.74785371 |
| 147 | myeloid dendritic cell activation (GO:0001773) | 2.74371764 |
| 148 | pinocytosis (GO:0006907) | 2.74221150 |
| 149 | pyrimidine nucleoside salvage (GO:0043097) | 2.73885511 |
| 150 | pyrimidine-containing compound salvage (GO:0008655) | 2.73885511 |
| 151 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.73620516 |
| 152 | negative regulation of innate immune response (GO:0045824) | 2.73558959 |
| 153 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.73142034 |
| 154 | negative T cell selection (GO:0043383) | 2.73126395 |
| 155 | formation of translation preinitiation complex (GO:0001731) | 2.71560760 |
| 156 | macromolecular complex disassembly (GO:0032984) | 2.69153339 |
| 157 | negative regulation of T cell mediated immunity (GO:0002710) | 2.68963199 |
| 158 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.68785873 |
| 159 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.68785873 |
| 160 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.68330693 |
| 161 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.68330693 |
| 162 | response to type I interferon (GO:0034340) | 2.68092201 |
| 163 | regulation of granulocyte differentiation (GO:0030852) | 2.67055555 |
| 164 | diterpenoid biosynthetic process (GO:0016102) | 2.66877750 |
| 165 | type I interferon signaling pathway (GO:0060337) | 2.64618411 |
| 166 | cellular response to type I interferon (GO:0071357) | 2.64618411 |
| 167 | negative regulation of alpha-beta T cell activation (GO:0046636) | 2.64553379 |
| 168 | negative regulation of RNA splicing (GO:0033119) | 2.64144307 |
| 169 | protein localization to chromosome, centromeric region (GO:0071459) | 2.63589572 |
| 170 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.62928436 |
| 171 | leukocyte degranulation (GO:0043299) | 2.62566774 |
| 172 | IMP biosynthetic process (GO:0006188) | 2.59009911 |
| 173 | ribosome assembly (GO:0042255) | 2.56701450 |
| 174 | translation (GO:0006412) | 2.56230316 |
| 175 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.56018374 |
| 176 | DNA replication-independent nucleosome organization (GO:0034724) | 2.55354154 |
| 177 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.55354154 |
| 178 | sulfur amino acid catabolic process (GO:0000098) | 2.55313134 |
| 179 | spliceosomal snRNP assembly (GO:0000387) | 2.53010291 |
| 180 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.52397919 |
| 181 | UMP metabolic process (GO:0046049) | 2.52397919 |
| 182 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.52397919 |
| 183 | UMP biosynthetic process (GO:0006222) | 2.52397919 |
| 184 | folic acid-containing compound metabolic process (GO:0006760) | 2.51354211 |
| 185 | proline metabolic process (GO:0006560) | 2.48474740 |
| 186 | mRNA catabolic process (GO:0006402) | 2.48267271 |
| 187 | histone H2A acetylation (GO:0043968) | 2.46519290 |
| 188 | pyrimidine nucleobase metabolic process (GO:0006206) | 2.46379785 |
| 189 | mitochondrial RNA metabolic process (GO:0000959) | 2.46164912 |
| 190 | RNA catabolic process (GO:0006401) | 2.45808427 |
| 191 | negative regulation of cholesterol transport (GO:0032375) | 2.45434127 |
| 192 | negative regulation of sterol transport (GO:0032372) | 2.45434127 |
| 193 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.45124430 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.13634994 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.58641761 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.43150944 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.98748353 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.95516975 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.72950089 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.63949488 |
| 8 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.61814656 |
| 9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.47835082 |
| 10 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.46974317 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.45801824 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.40467596 |
| 13 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.40300505 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.35128781 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.31495980 |
| 16 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.30004021 |
| 17 | MYC_22102868_ChIP-Seq_BL_Human | 2.26340159 |
| 18 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.25983456 |
| 19 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.19511957 |
| 20 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.19188093 |
| 21 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.18678411 |
| 22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.17919007 |
| 23 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.17277371 |
| 24 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.16899417 |
| 25 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.13500706 |
| 26 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12301486 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.11153499 |
| 28 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.08321792 |
| 29 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.00203794 |
| 30 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.98711007 |
| 31 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.97919838 |
| 32 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.96221662 |
| 33 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95665294 |
| 34 | * VDR_21846776_ChIP-Seq_THP-1_Human | 1.94938950 |
| 35 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92314592 |
| 36 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.90306815 |
| 37 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.87122540 |
| 38 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.86841259 |
| 39 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.86833073 |
| 40 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.86551754 |
| 41 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.85646298 |
| 42 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.84208645 |
| 43 | SPI1_23127762_ChIP-Seq_K562_Human | 1.82992130 |
| 44 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.82413488 |
| 45 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.78735337 |
| 46 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.78330667 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.77454709 |
| 48 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.76435803 |
| 49 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.75662618 |
| 50 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.74940396 |
| 51 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.74118510 |
| 52 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.73127666 |
| 53 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72290811 |
| 54 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.67849499 |
| 55 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.65523940 |
| 56 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.64695436 |
| 57 | P68_20966046_ChIP-Seq_HELA_Human | 1.64317594 |
| 58 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.63298750 |
| 59 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.58530194 |
| 60 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.57377787 |
| 61 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.54900922 |
| 62 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.54585188 |
| 63 | MYB_26560356_Chip-Seq_TH2_Human | 1.53848691 |
| 64 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.53567428 |
| 65 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.53013945 |
| 66 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.51105218 |
| 67 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.50065431 |
| 68 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.49206749 |
| 69 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.49099315 |
| 70 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.48638520 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.47706566 |
| 72 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47603665 |
| 73 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.47446125 |
| 74 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.47140153 |
| 75 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.46864768 |
| 76 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.46627454 |
| 77 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.45123444 |
| 78 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.44822076 |
| 79 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43151300 |
| 80 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43063638 |
| 81 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42683215 |
| 82 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.42553953 |
| 83 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.42230029 |
| 84 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.41879386 |
| 85 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.40087617 |
| 86 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.38058994 |
| 87 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.37513093 |
| 88 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.35638003 |
| 89 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.35572853 |
| 90 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.35029971 |
| 91 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.34920772 |
| 92 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.33885238 |
| 93 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.33552458 |
| 94 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28714341 |
| 95 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.28576759 |
| 96 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.27304476 |
| 97 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.26553467 |
| 98 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.26532583 |
| 99 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.25906404 |
| 100 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.25480858 |
| 101 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.25141519 |
| 102 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.24948957 |
| 103 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24620228 |
| 104 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23747225 |
| 105 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.23611517 |
| 106 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.23364137 |
| 107 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.22602600 |
| 108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22334852 |
| 109 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22321342 |
| 110 | GATA1_19941826_ChIP-Seq_K562_Human | 1.22096117 |
| 111 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.21477653 |
| 112 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.21222879 |
| 113 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.20788437 |
| 114 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.20457891 |
| 115 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20092101 |
| 116 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.20078795 |
| 117 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.19928502 |
| 118 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19004375 |
| 119 | UTX_26944678_Chip-Seq_JUKART_Human | 1.17337374 |
| 120 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16934297 |
| 121 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.16898241 |
| 122 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.16638925 |
| 123 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.16458696 |
| 124 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15617080 |
| 125 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.15451754 |
| 126 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14966148 |
| 127 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.14535438 |
| 128 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.13951003 |
| 129 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12924196 |
| 130 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12754334 |
| 131 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.12411365 |
| 132 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.10110305 |
| 133 | * MAF_26560356_Chip-Seq_TH1_Human | 1.09597700 |
| 134 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.09572720 |
| 135 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.08827405 |
| 136 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.08108880 |
| 137 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.07001103 |
| 138 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.06354429 |
| 139 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.04397183 |
| 140 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.03690551 |
| 141 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.03665284 |
| 142 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03403987 |
| 143 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.03143230 |
| 144 | P300_27268052_Chip-Seq_Bcells_Human | 1.02392635 |
| 145 | * ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.00796798 |
| 146 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00673843 |
| 147 | * MAF_26560356_Chip-Seq_TH2_Human | 1.00643375 |
| 148 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00274658 |
| 149 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.99819258 |
| 150 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.99628093 |
| 151 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.97951144 |
| 152 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96891573 |
| 153 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95738160 |
| 154 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.95307956 |
| 155 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.95303663 |
| 156 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.94607314 |
| 157 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.92994404 |
| 158 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.92645753 |
| 159 | MYB_26560356_Chip-Seq_TH1_Human | 0.92146221 |
| 160 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.91882455 |
| 161 | GATA1_22025678_ChIP-Seq_K562_Human | 0.90752421 |
| 162 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.90657669 |
| 163 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.90343020 |
| 164 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.90298456 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.15480598 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.95248175 |
| 3 | MP0003303_peritoneal_inflammation | 3.73027085 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.53448142 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.28741747 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 3.16661068 |
| 7 | MP0005365_abnormal_bile_salt | 3.12491216 |
| 8 | MP0008260_abnormal_autophagy | 3.08580330 |
| 9 | MP0005058_abnormal_lysosome_morphology | 3.08424552 |
| 10 | MP0003724_increased_susceptibility_to | 3.05263964 |
| 11 | MP0009840_abnormal_foam_cell | 2.96454852 |
| 12 | MP0010094_abnormal_chromosome_stability | 2.81799674 |
| 13 | MP0009278_abnormal_bone_marrow | 2.80094288 |
| 14 | MP0002396_abnormal_hematopoietic_system | 2.77774312 |
| 15 | MP0002419_abnormal_innate_immunity | 2.77081471 |
| 16 | MP0004957_abnormal_blastocyst_morpholog | 2.76224225 |
| 17 | MP0008057_abnormal_DNA_replication | 2.70509618 |
| 18 | MP0008875_abnormal_xenobiotic_pharmacok | 2.64824148 |
| 19 | MP0003111_abnormal_nucleus_morphology | 2.57281423 |
| 20 | MP0003763_abnormal_thymus_physiology | 2.47774528 |
| 21 | MP0003077_abnormal_cell_cycle | 2.38097611 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.30511233 |
| 23 | MP0003252_abnormal_bile_duct | 2.29394055 |
| 24 | MP0006082_CNS_inflammation | 1.94766519 |
| 25 | MP0000685_abnormal_immune_system | 1.83344553 |
| 26 | MP0008058_abnormal_DNA_repair | 1.78306757 |
| 27 | MP0003183_abnormal_peptide_metabolism | 1.78178451 |
| 28 | MP0010329_abnormal_lipoprotein_level | 1.75139598 |
| 29 | MP0008007_abnormal_cellular_replicative | 1.73099845 |
| 30 | MP0004947_skin_inflammation | 1.68181975 |
| 31 | MP0005075_abnormal_melanosome_morpholog | 1.67561034 |
| 32 | MP0005083_abnormal_biliary_tract | 1.66007678 |
| 33 | MP0000609_abnormal_liver_physiology | 1.63914873 |
| 34 | MP0002398_abnormal_bone_marrow | 1.61265582 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.57459626 |
| 36 | MP0009764_decreased_sensitivity_to | 1.56364351 |
| 37 | MP0003656_abnormal_erythrocyte_physiolo | 1.55202963 |
| 38 | MP0000689_abnormal_spleen_morphology | 1.52445510 |
| 39 | MP0002722_abnormal_immune_system | 1.48263412 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.46365050 |
| 41 | MP0001800_abnormal_humoral_immune | 1.45590271 |
| 42 | MP0003436_decreased_susceptibility_to | 1.43222461 |
| 43 | MP0005671_abnormal_response_to | 1.42596825 |
| 44 | MP0001545_abnormal_hematopoietic_system | 1.41089515 |
| 45 | MP0005397_hematopoietic_system_phenotyp | 1.41089515 |
| 46 | MP0005332_abnormal_amino_acid | 1.40849901 |
| 47 | MP0000858_altered_metastatic_potential | 1.39123126 |
| 48 | MP0000490_abnormal_crypts_of | 1.38566117 |
| 49 | MP0003868_abnormal_feces_composition | 1.36889180 |
| 50 | MP0003828_pulmonary_edema | 1.36203367 |
| 51 | MP0002019_abnormal_tumor_incidence | 1.36069627 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.33784207 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.32178062 |
| 54 | MP0001764_abnormal_homeostasis | 1.32110655 |
| 55 | MP0001835_abnormal_antigen_presentation | 1.31857503 |
| 56 | MP0002429_abnormal_blood_cell | 1.30615706 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.30244747 |
| 58 | MP0002166_altered_tumor_susceptibility | 1.29760998 |
| 59 | MP0001730_embryonic_growth_arrest | 1.29697254 |
| 60 | MP0001986_abnormal_taste_sensitivity | 1.29167650 |
| 61 | MP0000716_abnormal_immune_system | 1.28155986 |
| 62 | MP0000703_abnormal_thymus_morphology | 1.28036599 |
| 63 | MP0000350_abnormal_cell_proliferation | 1.27133848 |
| 64 | MP0006036_abnormal_mitochondrial_physio | 1.25995530 |
| 65 | MP0005025_abnormal_response_to | 1.25552207 |
| 66 | MP0003718_maternal_effect | 1.24533853 |
| 67 | MP0005319_abnormal_enzyme/_coenzyme | 1.23938041 |
| 68 | MP0005310_abnormal_salivary_gland | 1.23061488 |
| 69 | MP0000598_abnormal_liver_morphology | 1.21008107 |
| 70 | MP0003866_abnormal_defecation | 1.19377697 |
| 71 | MP0002723_abnormal_immune_serum | 1.19076277 |
| 72 | MP0010155_abnormal_intestine_physiology | 1.19010525 |
| 73 | MP0009785_altered_susceptibility_to | 1.18944793 |
| 74 | MP0003075_altered_response_to | 1.16438017 |
| 75 | MP0002420_abnormal_adaptive_immunity | 1.14288168 |
| 76 | MP0001819_abnormal_immune_cell | 1.11981783 |
| 77 | MP0001666_abnormal_nutrient_absorption | 1.11303219 |
| 78 | MP0005076_abnormal_cell_differentiation | 1.10928808 |
| 79 | MP0008469_abnormal_protein_level | 1.06597953 |
| 80 | MP0004381_abnormal_hair_follicle | 1.05886852 |
| 81 | MP0002998_abnormal_bone_remodeling | 1.05600287 |
| 82 | MP0002928_abnormal_bile_duct | 1.05147068 |
| 83 | MP0001873_stomach_inflammation | 1.04510303 |
| 84 | MP0000313_abnormal_cell_death | 1.04109425 |
| 85 | MP0002452_abnormal_antigen_presenting | 1.01354589 |
| 86 | MP0008932_abnormal_embryonic_tissue | 1.01084031 |
| 87 | MP0000477_abnormal_intestine_morphology | 0.98644518 |
| 88 | MP0003786_premature_aging | 0.97682845 |
| 89 | MP0001790_abnormal_immune_system | 0.97372596 |
| 90 | MP0005387_immune_system_phenotype | 0.97372596 |
| 91 | MP0002080_prenatal_lethality | 0.97070573 |
| 92 | MP0001663_abnormal_digestive_system | 0.93979323 |
| 93 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.93932421 |
| 94 | MP0000015_abnormal_ear_pigmentation | 0.92898388 |
| 95 | MP0004510_myositis | 0.92474513 |
| 96 | MP0005408_hypopigmentation | 0.91775352 |
| 97 | MP0000604_amyloidosis | 0.91345924 |
| 98 | MP0002118_abnormal_lipid_homeostasis | 0.88938173 |
| 99 | MP0005220_abnormal_exocrine_pancreas | 0.86972990 |
| 100 | MP0000678_abnormal_parathyroid_gland | 0.86900381 |
| 101 | MP0005451_abnormal_body_composition | 0.86369503 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 0.85899251 |
| 103 | MP0009763_increased_sensitivity_to | 0.85730025 |
| 104 | MP0001845_abnormal_inflammatory_respons | 0.85727944 |
| 105 | MP0001853_heart_inflammation | 0.85447332 |
| 106 | MP0005000_abnormal_immune_tolerance | 0.84795444 |
| 107 | MP0001697_abnormal_embryo_size | 0.84231429 |
| 108 | MP0009643_abnormal_urine_homeostasis | 0.83630376 |
| 109 | MP0005380_embryogenesis_phenotype | 0.83437087 |
| 110 | MP0001672_abnormal_embryogenesis/_devel | 0.83437087 |
| 111 | MP0006035_abnormal_mitochondrial_morpho | 0.83365529 |
| 112 | MP0009379_abnormal_foot_pigmentation | 0.82117663 |
| 113 | MP0008877_abnormal_DNA_methylation | 0.81955629 |
| 114 | MP0002132_abnormal_respiratory_system | 0.81172385 |
| 115 | MP0000465_gastrointestinal_hemorrhage | 0.81112080 |
| 116 | MP0002095_abnormal_skin_pigmentation | 0.80527574 |
| 117 | MP0001851_eye_inflammation | 0.80425335 |
| 118 | MP0002138_abnormal_hepatobiliary_system | 0.79510477 |
| 119 | MP0003567_abnormal_fetal_cardiomyocyte | 0.78961630 |
| 120 | MP0005166_decreased_susceptibility_to | 0.78504593 |
| 121 | MP0005167_abnormal_blood-brain_barrier | 0.75981017 |
| 122 | MP0003186_abnormal_redox_activity | 0.75963235 |
| 123 | MP0004185_abnormal_adipocyte_glucose | 0.75445505 |
| 124 | MP0003123_paternal_imprinting | 0.73996276 |
| 125 | MP0002405_respiratory_system_inflammati | 0.73520505 |
| 126 | MP0005636_abnormal_mineral_homeostasis | 0.73387607 |
| 127 | MP0003984_embryonic_growth_retardation | 0.72604665 |
| 128 | MP0005174_abnormal_tail_pigmentation | 0.72481283 |
| 129 | MP0003172_abnormal_lysosome_physiology | 0.72416702 |
| 130 | MP0001929_abnormal_gametogenesis | 0.71369073 |
| 131 | MP0003300_gastrointestinal_ulcer | 0.70751507 |
| 132 | MP0003795_abnormal_bone_structure | 0.68632985 |
| 133 | MP0004883_abnormal_blood_vessel | 0.67245747 |
| 134 | MP0002277_abnormal_respiratory_mucosa | 0.64152339 |
| 135 | MP0000343_altered_response_to | 0.63737891 |
| 136 | MP0005390_skeleton_phenotype | 0.63374863 |
| 137 | MP0002933_joint_inflammation | 0.63087484 |
| 138 | MP0005666_abnormal_adipose_tissue | 0.62433828 |
| 139 | MP0005164_abnormal_response_to | 0.58876659 |
| 140 | MP0000249_abnormal_blood_vessel | 0.58313848 |
| 141 | MP0000358_abnormal_cell_content/ | 0.57884917 |
| 142 | MP0003690_abnormal_glial_cell | 0.55582432 |
| 143 | MP0009931_abnormal_skin_appearance | 0.54653921 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.33107114 |
| 2 | Recurrent abscess formation (HP:0002722) | 5.20948807 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.12704065 |
| 4 | Abnormality of macrophages (HP:0004311) | 4.61470846 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.56377513 |
| 6 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.50888346 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.25246375 |
| 8 | Abnormal number of erythroid precursors (HP:0012131) | 4.22623114 |
| 9 | Chronic obstructive pulmonary disease (HP:0006510) | 4.09401345 |
| 10 | Obstructive lung disease (HP:0006536) | 4.09401345 |
| 11 | Myositis (HP:0100614) | 4.03471024 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.88840047 |
| 13 | Hypobetalipoproteinemia (HP:0003563) | 3.79020670 |
| 14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.76803762 |
| 15 | Abnormality of the fingertips (HP:0001211) | 3.69196927 |
| 16 | Oral leukoplakia (HP:0002745) | 3.67627294 |
| 17 | Abnormality of glycolipid metabolism (HP:0010969) | 3.61265605 |
| 18 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.61265605 |
| 19 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.61265605 |
| 20 | Prolonged partial thromboplastin time (HP:0003645) | 3.56962602 |
| 21 | Meningitis (HP:0001287) | 3.54218133 |
| 22 | Aplastic anemia (HP:0001915) | 3.50351233 |
| 23 | Deep venous thrombosis (HP:0002625) | 3.48522071 |
| 24 | Recurrent fungal infections (HP:0002841) | 3.46105938 |
| 25 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.36293638 |
| 26 | IgM deficiency (HP:0002850) | 3.34840953 |
| 27 | Gastrointestinal inflammation (HP:0004386) | 3.26898977 |
| 28 | Recurrent skin infections (HP:0001581) | 3.25872096 |
| 29 | Dysostosis multiplex (HP:0000943) | 3.23637188 |
| 30 | Reticulocytopenia (HP:0001896) | 3.23125537 |
| 31 | Intrahepatic cholestasis (HP:0001406) | 3.21044237 |
| 32 | Orchitis (HP:0100796) | 3.13790469 |
| 33 | Cellulitis (HP:0100658) | 3.11991175 |
| 34 | Pustule (HP:0200039) | 3.10719530 |
| 35 | Increased cerebral lipofuscin (HP:0011813) | 3.09204084 |
| 36 | Colitis (HP:0002583) | 3.04079588 |
| 37 | Inflammation of the large intestine (HP:0002037) | 3.02038935 |
| 38 | Stomatitis (HP:0010280) | 2.96484607 |
| 39 | Hyperglycinemia (HP:0002154) | 2.96030989 |
| 40 | Birth length less than 3rd percentile (HP:0003561) | 2.95339421 |
| 41 | Xanthomatosis (HP:0000991) | 2.95304225 |
| 42 | Gastrointestinal infarctions (HP:0005244) | 2.94067261 |
| 43 | Abnormality of lateral ventricle (HP:0030047) | 2.93761933 |
| 44 | Loss of speech (HP:0002371) | 2.93691028 |
| 45 | Macrocytic anemia (HP:0001972) | 2.88215029 |
| 46 | Increased IgE level (HP:0003212) | 2.83255711 |
| 47 | Optic neuritis (HP:0100653) | 2.82340235 |
| 48 | Retrobulbar optic neuritis (HP:0100654) | 2.82340235 |
| 49 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.81113662 |
| 50 | Recurrent cutaneous fungal infections (HP:0011370) | 2.81113662 |
| 51 | Vacuolated lymphocytes (HP:0001922) | 2.78656001 |
| 52 | Vasculitis (HP:0002633) | 2.78183159 |
| 53 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.71345430 |
| 54 | Gingivitis (HP:0000230) | 2.70788738 |
| 55 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.70687969 |
| 56 | Encephalitis (HP:0002383) | 2.70029548 |
| 57 | Agammaglobulinemia (HP:0004432) | 2.69574599 |
| 58 | Recurrent viral infections (HP:0004429) | 2.68193798 |
| 59 | Hyperlipoproteinemia (HP:0010980) | 2.67767448 |
| 60 | Broad distal phalanx of finger (HP:0009836) | 2.66561968 |
| 61 | Thrombocytosis (HP:0001894) | 2.66231926 |
| 62 | Systemic lupus erythematosus (HP:0002725) | 2.65325168 |
| 63 | Granulocytopenia (HP:0001913) | 2.65007933 |
| 64 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.63192376 |
| 65 | Urticaria (HP:0001025) | 2.61424470 |
| 66 | Hyperglycinuria (HP:0003108) | 2.61175996 |
| 67 | Purpura (HP:0000979) | 2.61049394 |
| 68 | Abnormality of T cell physiology (HP:0011840) | 2.56918279 |
| 69 | Chest pain (HP:0100749) | 2.54281023 |
| 70 | Deep palmar crease (HP:0006191) | 2.53637310 |
| 71 | Multiple enchondromatosis (HP:0005701) | 2.53193077 |
| 72 | Spontaneous hematomas (HP:0007420) | 2.50235932 |
| 73 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.49918121 |
| 74 | Hypochromic anemia (HP:0001931) | 2.49789850 |
| 75 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.48671135 |
| 76 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.48671135 |
| 77 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.48671135 |
| 78 | Hyperammonemia (HP:0001987) | 2.48392830 |
| 79 | Hyperbilirubinemia (HP:0002904) | 2.48148560 |
| 80 | Selective tooth agenesis (HP:0001592) | 2.46438257 |
| 81 | Abnormality of glycine metabolism (HP:0010895) | 2.45212730 |
| 82 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.45212730 |
| 83 | Premature graying of hair (HP:0002216) | 2.44103331 |
| 84 | Hemorrhage of the eye (HP:0011885) | 2.43818364 |
| 85 | Recurrent bronchitis (HP:0002837) | 2.42759471 |
| 86 | Pallor (HP:0000980) | 2.39631435 |
| 87 | Abnormality of T cells (HP:0002843) | 2.36808047 |
| 88 | Abnormality of cochlea (HP:0000375) | 2.36491466 |
| 89 | Dicarboxylic aciduria (HP:0003215) | 2.35189704 |
| 90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.35189704 |
| 91 | Type I transferrin isoform profile (HP:0003642) | 2.33698684 |
| 92 | Joint hemorrhage (HP:0005261) | 2.33165133 |
| 93 | Hemoptysis (HP:0002105) | 2.31009710 |
| 94 | Ketosis (HP:0001946) | 2.30555086 |
| 95 | Spastic diplegia (HP:0001264) | 2.28652333 |
| 96 | Keratoconjunctivitis sicca (HP:0001097) | 2.28444879 |
| 97 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.27937051 |
| 98 | Hypoplasia of the thymus (HP:0000778) | 2.27928320 |
| 99 | Impulsivity (HP:0100710) | 2.27511053 |
| 100 | Increased IgM level (HP:0003496) | 2.26631159 |
| 101 | Osteomyelitis (HP:0002754) | 2.26171063 |
| 102 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.25425180 |
| 103 | Abnormality of the common coagulation pathway (HP:0010990) | 2.24147403 |
| 104 | Hypertensive crisis (HP:0100735) | 2.20787799 |
| 105 | Hepatosplenomegaly (HP:0001433) | 2.20657614 |
| 106 | Acute lymphatic leukemia (HP:0006721) | 2.19886698 |
| 107 | Hepatic necrosis (HP:0002605) | 2.18483807 |
| 108 | Abnormality of serum amino acid levels (HP:0003112) | 2.17621712 |
| 109 | Mucopolysacchariduria (HP:0008155) | 2.16790408 |
| 110 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16790408 |
| 111 | Ependymoma (HP:0002888) | 2.15741982 |
| 112 | Hepatocellular necrosis (HP:0001404) | 2.14571950 |
| 113 | Thoracic kyphosis (HP:0002942) | 2.13414556 |
| 114 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.11790674 |
| 115 | Acanthocytosis (HP:0001927) | 2.11637146 |
| 116 | Neuronal loss in central nervous system (HP:0002529) | 2.11514996 |
| 117 | Cellular immunodeficiency (HP:0005374) | 2.11158456 |
| 118 | Chronic otitis media (HP:0000389) | 2.10156765 |
| 119 | Colon cancer (HP:0003003) | 2.09933927 |
| 120 | Poikilocytosis (HP:0004447) | 2.07354306 |
| 121 | Delayed epiphyseal ossification (HP:0002663) | 2.06861349 |
| 122 | Brushfield spots (HP:0001088) | 2.06100553 |
| 123 | Nasal polyposis (HP:0100582) | 2.05962601 |
| 124 | Combined immunodeficiency (HP:0005387) | 2.05936756 |
| 125 | Opisthotonus (HP:0002179) | 2.05900792 |
| 126 | Pancytopenia (HP:0001876) | 2.05218485 |
| 127 | Reduced antithrombin III activity (HP:0001976) | 2.05158180 |
| 128 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.04101884 |
| 129 | Absent/shortened dynein arms (HP:0200106) | 2.04101884 |
| 130 | Hypolipoproteinemia (HP:0010981) | 2.04064491 |
| 131 | Cerebral hypomyelination (HP:0006808) | 2.03140789 |
| 132 | Metaphyseal cupping (HP:0003021) | 2.03049686 |
| 133 | Abnormality of reticulocytes (HP:0004312) | 2.02569009 |
| 134 | Autoimmune thrombocytopenia (HP:0001973) | 2.01545315 |
| 135 | Disinhibition (HP:0000734) | 2.01454419 |
| 136 | Abnormality of the nasal mucosa (HP:0000433) | 2.00997478 |
| 137 | Epistaxis (HP:0000421) | 2.00704954 |
| 138 | Microretrognathia (HP:0000308) | 2.00492463 |
| 139 | Gastrointestinal stroma tumor (HP:0100723) | 1.99803251 |
| 140 | Leukocytosis (HP:0001974) | 1.98826146 |
| 141 | Basal cell carcinoma (HP:0002671) | 1.98297316 |
| 142 | Abnormality of B cell number (HP:0010975) | 1.97710544 |
| 143 | B lymphocytopenia (HP:0010976) | 1.97710544 |
| 144 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.97461721 |
| 145 | Keratoconjunctivitis (HP:0001096) | 1.97287919 |
| 146 | Abnormality of methionine metabolism (HP:0010901) | 1.96504122 |
| 147 | Progressive muscle weakness (HP:0003323) | 1.96312053 |
| 148 | Personality changes (HP:0000751) | 1.96197993 |
| 149 | Abnormality of nucleobase metabolism (HP:0010932) | 1.95432885 |
| 150 | Bone marrow hypocellularity (HP:0005528) | 1.95235748 |
| 151 | Papilloma (HP:0012740) | 1.94802193 |
| 152 | Verrucae (HP:0200043) | 1.94802193 |
| 153 | Pulmonary infiltrates (HP:0002113) | 1.94307190 |
| 154 | Lymphopenia (HP:0001888) | 1.94164802 |
| 155 | Panhypogammaglobulinemia (HP:0003139) | 1.92456468 |
| 156 | Sepsis (HP:0100806) | 1.92442020 |
| 157 | Polygenic inheritance (HP:0010982) | 1.92287448 |
| 158 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.91730121 |
| 159 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.91730121 |
| 160 | Prolonged bleeding time (HP:0003010) | 1.91241224 |
| 161 | Slow saccadic eye movements (HP:0000514) | 1.91193754 |
| 162 | Late onset (HP:0003584) | 1.90293726 |
| 163 | Ragged-red muscle fibers (HP:0003200) | 1.90149108 |
| 164 | Delayed CNS myelination (HP:0002188) | 1.89715539 |
| 165 | Complement deficiency (HP:0004431) | 1.89421370 |
| 166 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.88306383 |
| 167 | Rough bone trabeculation (HP:0100670) | 1.88160081 |
| 168 | Malnutrition (HP:0004395) | 1.87720408 |
| 169 | Restrictive lung disease (HP:0002091) | 1.87372940 |
| 170 | Abnormality of the intrinsic pathway (HP:0010989) | 1.84840045 |
| 171 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.84671723 |
| 172 | Lymphoma (HP:0002665) | 1.84508828 |
| 173 | Abnormality of the thoracic spine (HP:0100711) | 1.82557676 |
| 174 | Petechiae (HP:0000967) | 1.82081536 |
| 175 | Microcytic anemia (HP:0001935) | 1.81261271 |
| 176 | Increased serum ferritin (HP:0003281) | 1.81190014 |
| 177 | IgG deficiency (HP:0004315) | 1.80704767 |
| 178 | Megaloblastic anemia (HP:0001889) | 1.80453449 |
| 179 | Death in childhood (HP:0003819) | 1.79371341 |
| 180 | Gingival bleeding (HP:0000225) | 1.78273566 |
| 181 | Recurrent sinusitis (HP:0011108) | 1.76449694 |
| 182 | Abnormality of iron homeostasis (HP:0011031) | 1.76090301 |
| 183 | Increased serum lactate (HP:0002151) | 1.75972566 |
| 184 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.75899193 |
| 185 | Lethargy (HP:0001254) | 1.75709919 |
| 186 | 11 pairs of ribs (HP:0000878) | 1.75369883 |
| 187 | Gout (HP:0001997) | 1.75162168 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.82398714 |
| 2 | ACVR1B | 3.73245235 |
| 3 | BUB1 | 3.46502846 |
| 4 | WEE1 | 3.29156890 |
| 5 | MAP3K10 | 3.11739571 |
| 6 | MAP4K1 | 3.10211408 |
| 7 | ERN1 | 2.96511557 |
| 8 | BCKDK | 2.84546892 |
| 9 | FLT3 | 2.80075914 |
| 10 | NME2 | 2.60877884 |
| 11 | EIF2AK1 | 2.42792104 |
| 12 | PRPF4B | 2.33465003 |
| 13 | KIT | 2.18738063 |
| 14 | TNK2 | 2.09492805 |
| 15 | FES | 2.05534544 |
| 16 | STK16 | 2.05187636 |
| 17 | CDK4 | 2.00843133 |
| 18 | SCYL2 | 1.92234006 |
| 19 | CDC7 | 1.89172637 |
| 20 | CSK | 1.74479656 |
| 21 | KDR | 1.72836753 |
| 22 | PKN2 | 1.70972675 |
| 23 | NEK2 | 1.70365951 |
| 24 | SIK3 | 1.66839861 |
| 25 | MAP3K14 | 1.63340690 |
| 26 | EEF2K | 1.63171214 |
| 27 | SRPK1 | 1.62280982 |
| 28 | MAP3K13 | 1.61193067 |
| 29 | TESK2 | 1.54042429 |
| 30 | CSF1R | 1.52835446 |
| 31 | SMG1 | 1.51711615 |
| 32 | TRIB3 | 1.50007135 |
| 33 | TEC | 1.48077935 |
| 34 | GRK6 | 1.44845208 |
| 35 | ZAP70 | 1.44663191 |
| 36 | MARK2 | 1.44405292 |
| 37 | TGFBR1 | 1.42623625 |
| 38 | IRAK3 | 1.41071120 |
| 39 | HCK | 1.38160880 |
| 40 | TLK1 | 1.37131850 |
| 41 | BTK | 1.36548420 |
| 42 | MAP3K7 | 1.35105343 |
| 43 | EIF2AK3 | 1.31337950 |
| 44 | RAF1 | 1.30646889 |
| 45 | TYK2 | 1.26641587 |
| 46 | DYRK3 | 1.24121853 |
| 47 | CDK7 | 1.23279372 |
| 48 | CCNB1 | 1.21237324 |
| 49 | TSSK6 | 1.19374975 |
| 50 | TTK | 1.17969009 |
| 51 | KSR2 | 1.14779892 |
| 52 | TAOK2 | 1.14378631 |
| 53 | MAP3K3 | 1.14265775 |
| 54 | PLK1 | 1.14122683 |
| 55 | MATK | 1.11548817 |
| 56 | PRKD2 | 1.04950986 |
| 57 | SIK1 | 1.04699434 |
| 58 | STK10 | 1.04293043 |
| 59 | IRAK2 | 1.02397444 |
| 60 | MARK3 | 1.01496889 |
| 61 | STK38 | 1.01386143 |
| 62 | JAK2 | 1.00069151 |
| 63 | STK38L | 0.99668429 |
| 64 | FGR | 0.98528492 |
| 65 | MAP3K1 | 0.97418965 |
| 66 | FGFR4 | 0.96986372 |
| 67 | RPS6KB2 | 0.96326628 |
| 68 | AURKB | 0.95927487 |
| 69 | TBK1 | 0.94923626 |
| 70 | ILK | 0.94499438 |
| 71 | ATR | 0.93264885 |
| 72 | MAP2K2 | 0.92101135 |
| 73 | PIM2 | 0.88891961 |
| 74 | RPS6KL1 | 0.88724451 |
| 75 | RPS6KC1 | 0.88724451 |
| 76 | PASK | 0.88634200 |
| 77 | CHEK2 | 0.87753422 |
| 78 | TAOK3 | 0.83886717 |
| 79 | MAPK11 | 0.83179686 |
| 80 | SYK | 0.82779373 |
| 81 | NUAK1 | 0.80536692 |
| 82 | VRK1 | 0.76324450 |
| 83 | RPS6KA6 | 0.76089585 |
| 84 | AURKA | 0.74828180 |
| 85 | CDK19 | 0.74711871 |
| 86 | BRAF | 0.74096460 |
| 87 | LRRK2 | 0.73563675 |
| 88 | TXK | 0.73094418 |
| 89 | IKBKE | 0.71641277 |
| 90 | MAP3K8 | 0.70382950 |
| 91 | TESK1 | 0.69564664 |
| 92 | PDPK1 | 0.68259559 |
| 93 | MAP2K3 | 0.67585123 |
| 94 | CDC42BPA | 0.66723047 |
| 95 | HIPK2 | 0.65965969 |
| 96 | CDK8 | 0.65432774 |
| 97 | IRAK1 | 0.65362117 |
| 98 | PDK1 | 0.63415624 |
| 99 | DYRK1B | 0.61179187 |
| 100 | BLK | 0.60706675 |
| 101 | MAPK12 | 0.60557141 |
| 102 | BRSK2 | 0.60489801 |
| 103 | MAP3K11 | 0.59639284 |
| 104 | PTK6 | 0.58762491 |
| 105 | PIK3CA | 0.58704530 |
| 106 | PAK4 | 0.58528514 |
| 107 | PIM1 | 0.57175348 |
| 108 | NEK9 | 0.56913558 |
| 109 | CHEK1 | 0.56494529 |
| 110 | CDK6 | 0.55698230 |
| 111 | LCK | 0.55471114 |
| 112 | CSNK2A2 | 0.55362903 |
| 113 | DAPK1 | 0.55151534 |
| 114 | CDK12 | 0.54733519 |
| 115 | LYN | 0.54166580 |
| 116 | EPHB1 | 0.53101949 |
| 117 | IKBKB | 0.52813409 |
| 118 | STK4 | 0.52669642 |
| 119 | WNK1 | 0.51811792 |
| 120 | MAPK7 | 0.51326368 |
| 121 | TNIK | 0.50967056 |
| 122 | RPS6KA2 | 0.50600775 |
| 123 | TGFBR2 | 0.50535427 |
| 124 | MAPK4 | 0.49993519 |
| 125 | CDK2 | 0.49948286 |
| 126 | RPS6KA4 | 0.49787793 |
| 127 | JAK3 | 0.47618752 |
| 128 | MAP2K6 | 0.46307881 |
| 129 | CSNK2A1 | 0.44992227 |
| 130 | NLK | 0.44134513 |
| 131 | ITK | 0.43999412 |
| 132 | BRD4 | 0.42242071 |
| 133 | CLK1 | 0.40349884 |
| 134 | IRAK4 | 0.39114414 |
| 135 | BRSK1 | 0.38004477 |
| 136 | MTOR | 0.37926593 |
| 137 | ICK | 0.37474840 |
| 138 | FYN | 0.36871752 |
| 139 | RPS6KA1 | 0.36226587 |
| 140 | TAOK1 | 0.35970775 |
| 141 | RIPK1 | 0.35735214 |
| 142 | MAPK15 | 0.35355590 |
| 143 | PAK1 | 0.35261451 |
| 144 | MAP3K6 | 0.34450478 |
| 145 | SIK2 | 0.34287518 |
| 146 | MAPK3 | 0.33540202 |
| 147 | PTK2B | 0.29549185 |
| 148 | MAPK8 | 0.29324218 |
| 149 | JAK1 | 0.29124863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.47964992 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.70114672 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.47725293 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.14345238 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.89762018 |
| 6 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.84564037 |
| 7 | Homologous recombination_Homo sapiens_hsa03440 | 2.61801174 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.41953360 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.39407360 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.37777627 |
| 11 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.32749654 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.25031981 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.22593782 |
| 14 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.22235145 |
| 15 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.17770216 |
| 16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.15030095 |
| 17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.09728713 |
| 18 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.02039898 |
| 19 | Tuberculosis_Homo sapiens_hsa05152 | 2.00749736 |
| 20 | Sulfur relay system_Homo sapiens_hsa04122 | 1.98742507 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.96717973 |
| 22 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.94819153 |
| 23 | Proteasome_Homo sapiens_hsa03050 | 1.92129298 |
| 24 | Asthma_Homo sapiens_hsa05310 | 1.89707547 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.89553927 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.87275256 |
| 27 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.84659697 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.83598441 |
| 29 | RNA polymerase_Homo sapiens_hsa03020 | 1.82365328 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.78866750 |
| 31 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.71568351 |
| 32 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.67884451 |
| 33 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.63119867 |
| 34 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.61305114 |
| 35 | Lysosome_Homo sapiens_hsa04142 | 1.60043765 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.56437440 |
| 37 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.55754677 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.55281798 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.52204612 |
| 40 | RNA transport_Homo sapiens_hsa03013 | 1.50912508 |
| 41 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50409968 |
| 42 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.48687382 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.46703493 |
| 44 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.46317938 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 1.45927844 |
| 46 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.44902800 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.43792845 |
| 48 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.43286481 |
| 49 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.43015677 |
| 50 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42880273 |
| 51 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41576377 |
| 52 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.38837437 |
| 53 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.37276319 |
| 54 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.37078497 |
| 55 | Viral myocarditis_Homo sapiens_hsa05416 | 1.34715926 |
| 56 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.31910452 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.29502687 |
| 58 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.28173849 |
| 59 | Cell cycle_Homo sapiens_hsa04110 | 1.25828222 |
| 60 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.22989240 |
| 61 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.20609763 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 1.19666178 |
| 63 | Shigellosis_Homo sapiens_hsa05131 | 1.19658347 |
| 64 | Malaria_Homo sapiens_hsa05144 | 1.19381728 |
| 65 | Carbon metabolism_Homo sapiens_hsa01200 | 1.18319109 |
| 66 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.18097841 |
| 67 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.18070392 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.16779140 |
| 69 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.16392919 |
| 70 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.15858979 |
| 71 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.15635704 |
| 72 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.14221440 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13159564 |
| 74 | Phagosome_Homo sapiens_hsa04145 | 1.12920391 |
| 75 | Hepatitis B_Homo sapiens_hsa05161 | 1.11169222 |
| 76 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.10400372 |
| 77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.08912616 |
| 78 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.02717202 |
| 79 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.01966311 |
| 80 | Hepatitis C_Homo sapiens_hsa05160 | 1.00578248 |
| 81 | Peroxisome_Homo sapiens_hsa04146 | 0.99548836 |
| 82 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.99259305 |
| 83 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.97887145 |
| 84 | Salmonella infection_Homo sapiens_hsa05132 | 0.97854742 |
| 85 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.97583624 |
| 86 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.97233348 |
| 87 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.96852947 |
| 88 | RNA degradation_Homo sapiens_hsa03018 | 0.96614561 |
| 89 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.96118799 |
| 90 | Apoptosis_Homo sapiens_hsa04210 | 0.95709761 |
| 91 | Purine metabolism_Homo sapiens_hsa00230 | 0.94586106 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.93472684 |
| 93 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.90422900 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.89207157 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.86305099 |
| 96 | Platelet activation_Homo sapiens_hsa04611 | 0.80279721 |
| 97 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.79596621 |
| 98 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79125442 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78423981 |
| 100 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.74153445 |
| 101 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73612144 |
| 102 | Lysine degradation_Homo sapiens_hsa00310 | 0.73112083 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.72724542 |
| 104 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.71197426 |
| 105 | Basal transcription factors_Homo sapiens_hsa03022 | 0.70972656 |
| 106 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.70573360 |
| 107 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.70367493 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.70174731 |
| 109 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69853588 |
| 110 | Bladder cancer_Homo sapiens_hsa05219 | 0.69279383 |
| 111 | Histidine metabolism_Homo sapiens_hsa00340 | 0.69146628 |
| 112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67708930 |
| 113 | HTLV-I infection_Homo sapiens_hsa05166 | 0.67670738 |
| 114 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.66231953 |
| 115 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.65845897 |
| 116 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.65705328 |
| 117 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.65315222 |
| 118 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.65286594 |
| 119 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65135150 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62918372 |
| 121 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62364224 |
| 122 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62249951 |
| 123 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60290767 |
| 124 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.58645785 |
| 125 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58378421 |
| 126 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.58018739 |
| 127 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57855673 |
| 128 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57800502 |
| 129 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.57432820 |
| 130 | Retinol metabolism_Homo sapiens_hsa00830 | 0.56841513 |
| 131 | ABC transporters_Homo sapiens_hsa02010 | 0.55542552 |
| 132 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.55263058 |
| 133 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53793832 |
| 134 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.52722849 |
| 135 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52669896 |
| 136 | Metabolic pathways_Homo sapiens_hsa01100 | 0.52515608 |
| 137 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.51373775 |
| 138 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.50647404 |
| 139 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50121794 |
| 140 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.48607932 |
| 141 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.48556869 |
| 142 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.48249467 |
| 143 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47926562 |
| 144 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.47742802 |
| 145 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46511478 |
| 146 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46467315 |
| 147 | Colorectal cancer_Homo sapiens_hsa05210 | 0.45988052 |
| 148 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.45573355 |
| 149 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43680252 |
| 150 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43272415 |
| 151 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.42222380 |
| 152 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.42175144 |
| 153 | Measles_Homo sapiens_hsa05162 | 0.41935583 |
| 154 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41076593 |
| 155 | Endocytosis_Homo sapiens_hsa04144 | 0.40132109 |
| 156 | Galactose metabolism_Homo sapiens_hsa00052 | 0.39910530 |
| 157 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.38134026 |
| 158 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.38103965 |
| 159 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.37516787 |
| 160 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.37098980 |
| 161 | Insulin resistance_Homo sapiens_hsa04931 | 0.37041058 |
| 162 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35997139 |
| 163 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.33889997 |
| 164 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.32586694 |
| 165 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.32461147 |
| 166 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31749622 |
| 167 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.31360230 |
| 168 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.31181975 |
| 169 | Amoebiasis_Homo sapiens_hsa05146 | 0.30355212 |
| 170 | Protein export_Homo sapiens_hsa03060 | 0.29645651 |
| 171 | Thyroid cancer_Homo sapiens_hsa05216 | 0.29003832 |
| 172 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.27414765 |
| 173 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.26545730 |
| 174 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.24189493 |

